Clinical Trial Update: Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691) [Phase 3]

View source ↗

Summary

A Phase 3 fixed-dose safety and efficacy study evaluating asenapine for acute manic or mixed episodes in Bipolar I disorder has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Asenapine (asenapine)

Snippet

Sponsor: Organon and Co | Conditions: Bipolar 1 Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-04-24